Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
12/22/2009 | US7635774 Benzimidazole derivatives |
12/22/2009 | US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors |
12/22/2009 | US7635695 4-Amino-2-(4-methyl-thiophen-2-yl)thieno[3,2-c]pyridine-7-carboxylic acid amide; 4-amino-2-cyclopent-1-enyl-thieno[3,2-c]pyridine-7-carboxylic acid amide; for therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease |
12/22/2009 | CA2447166C Delivery of erectile dysfunction drugs through an inhalation route |
12/22/2009 | CA2446990C Delivery of sedative-hypnotics through an inhalation route |
12/22/2009 | CA2446917C Delivery of antipsychotics through an inhalation route |
12/22/2009 | CA2446916C Delivery of opioids through an inhalation route |
12/22/2009 | CA2423806C Modified carbocyanine dyes and their conjugates |
12/22/2009 | CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
12/22/2009 | CA2345297C Synthetic analogs of ecteinascidin-743 |
12/22/2009 | CA2290744C Cyclic diamine compounds and medicine containing the same |
12/22/2009 | CA2262435C Preparation of sterically hindered amine ethers |
12/17/2009 | WO2009151598A1 Diazacarbazoles and methods of use |
12/17/2009 | WO2009151589A1 Diazacarbazoles and methods of use |
12/17/2009 | WO2009150388A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
12/17/2009 | WO2009150381A2 Azacarboline derivatives, preparation method thereof and therapeutic use of same |
12/17/2009 | WO2009150240A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases |
12/17/2009 | WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
12/17/2009 | WO2009150139A2 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods |
12/17/2009 | WO2009150138A1 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use |
12/17/2009 | WO2009150129A1 Heterocyclic derivatives as hdac inhibitors |
12/17/2009 | WO2009149820A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
12/17/2009 | WO2009149819A1 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
12/17/2009 | WO2009130710A3 A process for the preparation of paliperidone intermediates |
12/17/2009 | WO2009129401A8 Kinase inhibitors |
12/17/2009 | WO2009109987A3 Fused pyrimidine derivatives as trpv3 modulators |
12/17/2009 | WO2009091374A3 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
12/17/2009 | WO2008144931A8 Compositions and methods for modulating gated ion channels |
12/17/2009 | US20090312553 N-type semiconductor materials for thin film transistors |
12/17/2009 | US20090312549 Method of preparation of azaindole derivatives |
12/17/2009 | US20090312548 Modified pictet-spengler reaction and products prepared therefrom |
12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
12/17/2009 | US20090312366 Novel p2x7r antagonists and their use |
12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
12/17/2009 | US20090312356 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
12/17/2009 | US20090312349 Anti-inflammatory medicaments |
12/17/2009 | US20090312335 Hiv Integrase Inhibitors |
12/17/2009 | US20090312326 Substituted imidazoles |
12/17/2009 | US20090312321 Compositions and methods for fgf receptor kinases inhibitors |
12/17/2009 | US20090312306 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
12/17/2009 | US20090312304 Organic compounds |
12/17/2009 | US20090312288 Kinase inhibitors |
12/17/2009 | CA2727680A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
12/17/2009 | CA2727669A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
12/17/2009 | CA2727373A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
12/17/2009 | CA2727245A1 Imidazole derivatives useful as inhibitors of faah |
12/17/2009 | CA2727243A1 Branched 3- and 6-substituted quinolines as cgrp receptor antagonists |
12/17/2009 | CA2727062A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases |
12/17/2009 | CA2727032A1 Novel tricyclic compounds |
12/17/2009 | CA2726114A1 Diazacarbazoles and methods of use |
12/17/2009 | CA2725754A1 Diazacarbazoles and methods of use |
12/17/2009 | CA2725093A1 Azacarboline derivatives, preparation method thereof and therapeutic us of same |
12/16/2009 | EP2133352A2 Crystal form of 9-hydroxy-risperidone (paliperidone) |
12/16/2009 | EP2133351A2 Crystal form of 9-hydroxy-risperidone (paliperidone) |
12/16/2009 | EP2133350A2 A method for the preparation of an enantiomerically pure benzazepine |
12/16/2009 | EP2133349A1 Kinase inhibitors |
12/16/2009 | EP2133340A1 Novel benzazepine derivatives |
12/16/2009 | EP2133336A1 Modified metal complexes and use thereof |
12/16/2009 | EP2133334A1 Heterocyclic derivatives as HDAC inhibitors |
12/16/2009 | EP2132196A1 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
12/16/2009 | EP2132157A1 Novel condensed ring aromatic compound and organic light-emitting device having the same |
12/16/2009 | EP2131656A2 Phthalazine derivatives |
12/16/2009 | EP1912644B1 N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and use thereof |
12/16/2009 | EP1576159B9 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
12/16/2009 | CN101605793A Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
12/16/2009 | CN101605792A Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613 |
12/16/2009 | CN101605791A 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
12/16/2009 | CN101605790A New aminopyrrolo[1,2-a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same |
12/16/2009 | CN101605789A Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor |
12/16/2009 | CN101605788A Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators |
12/16/2009 | CN101605787A Compounds modulating c-fms and/or c-kit activity and uses therefor |
12/16/2009 | CN101605786A Imidazopyridine inhibitors of iap |
12/16/2009 | CN101605785A Pyrido-pyrazine derivatives useful as herbicidal compounds |
12/16/2009 | CN101605780A New 2, 4-dianilinopyrimidines, preparation thereof as drugs,pharmaceutical compositions and use thereof essentially as IKK inhibitors |
12/16/2009 | CN101605544A CRTH2 antagonists |
12/16/2009 | CN101602763A Preparation method of oxymatrine |
12/16/2009 | CN101602741A Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
12/16/2009 | CN101602731A Metalloproteinase inhibitors |
12/16/2009 | CN100569773C Novel azaindole thiazolinones as anti-cancer agents |
12/16/2009 | CN100569772C Azaindoles useful as inhibitors of JAK and other protein kinases |
12/16/2009 | CN100569769C Compounds with antibacterial activity |
12/15/2009 | US7632948 reacting 8-amino-1,2,3,4-tetrahydro-isoquinoline with chloral hydrate and hydroxylamine hydrochloride to give an N-(1,2,3,4-tetrahydro-isoquinolin-8-yl)-2-hydroxyimino-acetamide, adding H2SO4 to provide a 2,3-dioxo-2,3,6,7,8,9-hexahydro-1H-pyrrolo[3,2-h]isoquinoline, finally reacting with butyrolactone |
12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
12/15/2009 | US7632839 Kinesin spindle protein (KSP) inhibitors, e.g., N-(3-amino-2-(R,S)-fluoropropyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-2-yl)-2-(R,S)-methylpropyl]-4-methylbenzamide; antiproliferative and -carcinogenic agents; side effects reduction |
12/15/2009 | US7632831 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
12/15/2009 | US7632578 Containing imidazo-pyridine compound |
12/10/2009 | WO2009149139A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/10/2009 | WO2009148341A1 Process for preparation of tadalafil |
12/10/2009 | WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials |
12/10/2009 | WO2009147476A1 Novel pde inhibitors, pharmaceutical compositions containing them and processes for their preparation |
12/10/2009 | WO2009147237A1 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics |
12/10/2009 | WO2009147190A1 Novel compounds |
12/10/2009 | WO2009147167A1 Indane derivatives as ampa receptor modulators |
12/10/2009 | WO2009147079A1 3,4-dihydropyrimidine trpa1 antagonists |
12/10/2009 | WO2009146696A1 Use of indole-3-carboxylic esters for inhibiting microsomal prostaglandin e2 synthase |
12/10/2009 | WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
12/10/2009 | US20090306388 Method for substituted ih-imidazo[4,5-c] pyridines |
12/10/2009 | US20090306386 Plant Extract Obtained by an Extraction Method by Means of Solvents of Plant Origin |
12/10/2009 | US20090306129 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |